Page last updated: 2024-12-09

apigetrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

apigetrin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

apigenin 7-O-beta-D-glucoside : A glycosyloxyflavone that is apigenin substituted by a beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5280704
CHEMBL ID487017
CHEBI ID16778
SCHEMBL ID146404
MeSH IDM0161545

Synonyms (98)

Synonym
CHEBI:16778 ,
5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4h-chromen-7-yl beta-d-glucopyranoside
DIVK1C_007023
5-hydroxy-2-(4-hydroxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one
4h-1-benzopyran-4-one, 7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-, apigenin 7-o-glucoside
apigenin 7-glucoside
apigenin-7-o-.beta.-d-glucopyranoside
SPECTRUM4_001741
SPECTRUM_000176
MEGXP0_001431
BSPBIO_002758
NCGC00178486-01
SPECTRUM5_000562
apigenin 7-o-.beta.-d-glucoside
apigenin 7-o-.beta.-d-glucopyranoside
cosmosiine
4h-1-benzopyran-4-one, 7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-
nsc-407303
cosmosioside
7-o-(.beta.-d-glucosyl)apigenin
7-o-beta-d-glucosyl-5,7,4'-trihydroxyflavone
cosmetin
578-74-5
7-(beta-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
cosmosiin
apigetrin
apigenin 7-o-beta-d-glucoside
C04608
KBIO2_003224
KBIO2_000656
KBIO3_002258
KBIO2_005792
KBIOSS_000656
KBIOGR_002182
KBIO1_001967
SPECTRUM3_001249
SPECTRUM2_001752
SPECPLUS_000927
SPBIO_001884
SPECTRUM211950
7-o-beta-d-glucosyl-apigenin
CHEMBL487017
HMS1923E03
A831652
5-hydroxy-2-(4-hydroxyphenyl)-7-[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one;apigenin 7-glucoside
5-hydroxy-2-(4-hydroxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
4-ethynyl-1,1-biphenyl
apigenin-7-o-glucoside
S9125
CCG-38803
einecs 209-430-5
unii-7of2s66pch
apigenin 7-o-beta-d-glucopyranoside
7-o-(beta-d-glucosyl)apigenin
cosemetin
nsc 407303
apigenin, 7-beta-d-glucopyranoside
7of2s66pch ,
4h-1-benzopyran-4-one, 7-(beta-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-
bdbm50378582
4',5,7-trihydroxyflavone 7-glucoside
apigenin 7-o-glucoside (constituent of chamomile) [dsc]
7-(.beta.-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
apigetrin [mi]
cosmoside
apigenin-7-glucoside [usp-rs]
BRD-K13642330-001-01-8
SCHEMBL146404
5-hydroxy-2-(4-hydroxyphenyl)-7-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
apigenin-7-glucoside
4h-1-benzopyran-4-one, 7-(b-d-glucopyranosyloxy)-5-hydroxy-2-(4-hydroxyphenyl)-
apigenin 7-o-beta-glucoside
AKOS025117305
mfcd00016787
HY-N0578
apigenin 7-glucoside, united states pharmacopeia (usp) reference standard
apigenin 7-glucoside, primary pharmaceutical reference standard
apigenin 7-glucoside, analytical standard
apigenin 7-glucoside, europepharmacopoeia (ep) reference standard
cosmociin
7-o-beta-d-glucosylapigenin
7-o-beta-d-glucopyranosylapigenin
4',5,7-trihydroxyflavone 7-beta-d-glucoside
apigenin 7-beta-glucopyranoside
apigenin 7-o-beta-glucopyranoside
CS-5931
apigenin 7-beta-d-glucoside
Q2858304
AS-75174
5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4h-chromen-4-one
5-hydroxy-2-(4-hydroxyphenyl)-7-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
apigenin-7-o-b-d-glucopyranoside
apigenin-7-o-glucoside 1000 microg/ml in acetone:dimethyl sulfoxide
apigetrin(apigenin-7-o-glucoside)
DTXSID401028774
apigenin-7-o-|a-d-glucoside
apigenin-7-glucoside (usp-rs)
apigenin 7-o-glucoside (constituent of chamomile)

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The method was fully validated and successfully applied to a pharmacokinetic study of AGL."( High-performance liquid chromatographic determination and pharmacokinetic study of apigenin-7-O-β-D-glucoside in rat plasma after intravenous administration.
Cao, Q; Chen, Z; Jiang, H; Li, X; Meng, F; Meng, S; Ying, X; Zhu, X, 2011
)
0.37
" The method was fully validated and successfully applied to a pharmacokinetic study of LGL and AGL in rat plasma after the intravenous administration of HSE."( LC determination of luteolin-7-O-β-D-glucoside and apigenin-7-O-β-D-glucoside in rat plasma after administration of Humulus scandens extract and its application to pharmacokinetic studies.
Cao, Q; Chen, Z; Jiang, H; Meng, F; Meng, S; Wang, L; Ying, X; Zhu, X, 2012
)
0.38

Compound-Compound Interactions

ExcerptReferenceRelevance
"In this study, a new method based on ultrafiltration liquid chromatography-mass spectrometry (UF-LC-MS) combined with enzyme channel blocking (ECB) was developed to discover bioactive components from herbal medicines."( Screening for selective inhibitors of xanthine oxidase from Flos Chrysanthemum using ultrafiltration LC-MS combined with enzyme channel blocking.
Chen, J; Fu, Y; Li, P; Mo, HY; Song, HP; Zhang, H; Zhang, M, 2014
)
0.4

Bioavailability

ExcerptReferenceRelevance
", genistein) were comparable to well absorbed compounds, such as testosterone and propranolol."( Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model.
Hu, M; Liu, Y, 2002
)
0.31
"We investigated the impact of human intestinal microbiota on bioavailability of the flavone apigenin-7-glucoside (A7G) by comparing germ-free and human microbiota-associated (HMA) rats."( The bioavailability of apigenin-7-glucoside is influenced by human intestinal microbiota in rats.
Blaut, M; Braune, A; Hanske, L; Loh, G; Sczesny, S, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
non-steroidal anti-inflammatory drugAn anti-inflammatory drug that is not a steroid. In addition to anti-inflammatory actions, non-steroidal anti-inflammatory drugs have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
beta-D-glucosideAny D-glucoside in which the anomeric centre has beta-configuration.
dihydroxyflavoneAny hydroxyflavone in which two ring hydrogens are replaced by hydroxy substituents.
glycosyloxyflavoneA member of the class of flavones having one or more glycosyl residues attached at unspecified positions.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
apigenin glycosides biosynthesis011
apigenin glycosides biosynthesis114

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))IC50 (µMol)46.90000.00000.503510.0000AID455703
Neuraminidase Influenza A virus (A/Wilson-Smith/1933(H1N1))Ki53.80000.00011.78687.7000AID455703
SialidaseClostridium perfringensIC50 (µMol)39.30000.00102.45729.8000AID455702
TyrosinaseHomo sapiens (human)IC50 (µMol)50.00000.02304.459310.0000AID1594853
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tumor necrosis factorHomo sapiens (human)Kd0.20000.00274.29269.7700AID1156798
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (188)

Processvia Protein(s)Taxonomy
positive regulation of gene expressionTumor necrosis factorHomo sapiens (human)
negative regulation of gene expressionTumor necrosis factorHomo sapiens (human)
positive regulation of MAP kinase activityTumor necrosis factorHomo sapiens (human)
positive regulation of MAPK cascadeTumor necrosis factorHomo sapiens (human)
positive regulation of interleukin-33 productionTumor necrosis factorHomo sapiens (human)
positive regulation of cytokine production involved in inflammatory responseTumor necrosis factorHomo sapiens (human)
negative regulation of miRNA transcriptionTumor necrosis factorHomo sapiens (human)
positive regulation of miRNA transcriptionTumor necrosis factorHomo sapiens (human)
negative regulation of signaling receptor activityTumor necrosis factorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IITumor necrosis factorHomo sapiens (human)
positive regulation of gene expressionTumor necrosis factorHomo sapiens (human)
negative regulation of gene expressionTumor necrosis factorHomo sapiens (human)
positive regulation of interleukin-8 productionTumor necrosis factorHomo sapiens (human)
negative regulation of cysteine-type endopeptidase activity involved in apoptotic processTumor necrosis factorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IITumor necrosis factorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTumor necrosis factorHomo sapiens (human)
positive regulation of calcineurin-NFAT signaling cascadeTumor necrosis factorHomo sapiens (human)
positive regulation of cytokine production involved in inflammatory responseTumor necrosis factorHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionTumor necrosis factorHomo sapiens (human)
positive regulation of synoviocyte proliferationTumor necrosis factorHomo sapiens (human)
positive regulation of I-kappaB phosphorylationTumor necrosis factorHomo sapiens (human)
negative regulation of apoptotic signaling pathwayTumor necrosis factorHomo sapiens (human)
negative regulation of transcription by RNA polymerase IITumor necrosis factorHomo sapiens (human)
response to hypoxiaTumor necrosis factorHomo sapiens (human)
microglial cell activationTumor necrosis factorHomo sapiens (human)
positive regulation of cytokine productionTumor necrosis factorHomo sapiens (human)
positive regulation of protein phosphorylationTumor necrosis factorHomo sapiens (human)
negative regulation of endothelial cell proliferationTumor necrosis factorHomo sapiens (human)
negative regulation of L-glutamate import across plasma membraneTumor necrosis factorHomo sapiens (human)
macrophage activation involved in immune responseTumor necrosis factorHomo sapiens (human)
chronic inflammatory response to antigenic stimulusTumor necrosis factorHomo sapiens (human)
leukocyte migration involved in inflammatory responseTumor necrosis factorHomo sapiens (human)
regulation of immunoglobulin productionTumor necrosis factorHomo sapiens (human)
negative regulation of cytokine production involved in immune responseTumor necrosis factorHomo sapiens (human)
positive regulation of chronic inflammatory response to antigenic stimulusTumor necrosis factorHomo sapiens (human)
positive regulation of humoral immune response mediated by circulating immunoglobulinTumor necrosis factorHomo sapiens (human)
skeletal muscle contractionTumor necrosis factorHomo sapiens (human)
negative regulation of systemic arterial blood pressureTumor necrosis factorHomo sapiens (human)
glucose metabolic processTumor necrosis factorHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTumor necrosis factorHomo sapiens (human)
inflammatory responseTumor necrosis factorHomo sapiens (human)
humoral immune responseTumor necrosis factorHomo sapiens (human)
JNK cascadeTumor necrosis factorHomo sapiens (human)
circadian rhythmTumor necrosis factorHomo sapiens (human)
extrinsic apoptotic signaling pathway via death domain receptorsTumor necrosis factorHomo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damageTumor necrosis factorHomo sapiens (human)
response to xenobiotic stimulusTumor necrosis factorHomo sapiens (human)
response to virusTumor necrosis factorHomo sapiens (human)
response to salt stressTumor necrosis factorHomo sapiens (human)
response to fructoseTumor necrosis factorHomo sapiens (human)
negative regulation of heart rateTumor necrosis factorHomo sapiens (human)
vascular endothelial growth factor productionTumor necrosis factorHomo sapiens (human)
positive regulation of gene expressionTumor necrosis factorHomo sapiens (human)
negative regulation of gene expressionTumor necrosis factorHomo sapiens (human)
negative regulation of lipid storageTumor necrosis factorHomo sapiens (human)
response to activityTumor necrosis factorHomo sapiens (human)
regulation of metabolic processTumor necrosis factorHomo sapiens (human)
calcium-mediated signalingTumor necrosis factorHomo sapiens (human)
extracellular matrix organizationTumor necrosis factorHomo sapiens (human)
osteoclast differentiationTumor necrosis factorHomo sapiens (human)
sequestering of triglycerideTumor necrosis factorHomo sapiens (human)
cortical actin cytoskeleton organizationTumor necrosis factorHomo sapiens (human)
positive regulation of protein-containing complex assemblyTumor necrosis factorHomo sapiens (human)
positive regulation of fever generationTumor necrosis factorHomo sapiens (human)
negative regulation of myelinationTumor necrosis factorHomo sapiens (human)
response to nutrient levelsTumor necrosis factorHomo sapiens (human)
negative regulation of interleukin-6 productionTumor necrosis factorHomo sapiens (human)
positive regulation of chemokine productionTumor necrosis factorHomo sapiens (human)
positive regulation of fractalkine productionTumor necrosis factorHomo sapiens (human)
positive regulation of type II interferon productionTumor necrosis factorHomo sapiens (human)
positive regulation of interleukin-1 beta productionTumor necrosis factorHomo sapiens (human)
positive regulation of interleukin-18 productionTumor necrosis factorHomo sapiens (human)
positive regulation of interleukin-6 productionTumor necrosis factorHomo sapiens (human)
positive regulation of interleukin-8 productionTumor necrosis factorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationTumor necrosis factorHomo sapiens (human)
tumor necrosis factor-mediated signaling pathwayTumor necrosis factorHomo sapiens (human)
positive regulation of heterotypic cell-cell adhesionTumor necrosis factorHomo sapiens (human)
toll-like receptor 3 signaling pathwayTumor necrosis factorHomo sapiens (human)
negative regulation of myosin-light-chain-phosphatase activityTumor necrosis factorHomo sapiens (human)
response to isolation stressTumor necrosis factorHomo sapiens (human)
response to macrophage colony-stimulating factorTumor necrosis factorHomo sapiens (human)
vasodilationTumor necrosis factorHomo sapiens (human)
positive regulation of tyrosine phosphorylation of STAT proteinTumor necrosis factorHomo sapiens (human)
positive regulation of apoptotic processTumor necrosis factorHomo sapiens (human)
positive regulation of programmed cell deathTumor necrosis factorHomo sapiens (human)
regulation of canonical NF-kappaB signal transductionTumor necrosis factorHomo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionTumor necrosis factorHomo sapiens (human)
negative regulation of protein-containing complex disassemblyTumor necrosis factorHomo sapiens (human)
positive regulation of protein-containing complex disassemblyTumor necrosis factorHomo sapiens (human)
positive regulation of cysteine-type endopeptidase activity involved in apoptotic processTumor necrosis factorHomo sapiens (human)
positive regulation of MAP kinase activityTumor necrosis factorHomo sapiens (human)
positive regulation of MAPK cascadeTumor necrosis factorHomo sapiens (human)
phosphatidylinositol 3-kinase/protein kinase B signal transductionTumor necrosis factorHomo sapiens (human)
positive regulation of JUN kinase activityTumor necrosis factorHomo sapiens (human)
positive regulation of neuron apoptotic processTumor necrosis factorHomo sapiens (human)
negative regulation of blood vessel endothelial cell migrationTumor necrosis factorHomo sapiens (human)
negative regulation of viral genome replicationTumor necrosis factorHomo sapiens (human)
positive regulation of nitric oxide biosynthetic processTumor necrosis factorHomo sapiens (human)
response to ethanolTumor necrosis factorHomo sapiens (human)
regulation of fat cell differentiationTumor necrosis factorHomo sapiens (human)
negative regulation of fat cell differentiationTumor necrosis factorHomo sapiens (human)
negative regulation of myoblast differentiationTumor necrosis factorHomo sapiens (human)
negative regulation of osteoblast differentiationTumor necrosis factorHomo sapiens (human)
positive regulation of osteoclast differentiationTumor necrosis factorHomo sapiens (human)
positive regulation of protein catabolic processTumor necrosis factorHomo sapiens (human)
positive regulation of action potentialTumor necrosis factorHomo sapiens (human)
positive regulation of cell adhesionTumor necrosis factorHomo sapiens (human)
positive regulation of mitotic nuclear divisionTumor necrosis factorHomo sapiens (human)
negative regulation of DNA-templated transcriptionTumor necrosis factorHomo sapiens (human)
positive regulation of DNA-templated transcriptionTumor necrosis factorHomo sapiens (human)
negative regulation of mitotic cell cycleTumor necrosis factorHomo sapiens (human)
positive regulation of transcription by RNA polymerase IITumor necrosis factorHomo sapiens (human)
positive regulation of translational initiation by ironTumor necrosis factorHomo sapiens (human)
negative regulation of glucose importTumor necrosis factorHomo sapiens (human)
positive regulation of JNK cascadeTumor necrosis factorHomo sapiens (human)
positive regulation of receptor signaling pathway via JAK-STATTumor necrosis factorHomo sapiens (human)
astrocyte activationTumor necrosis factorHomo sapiens (human)
embryonic digestive tract developmentTumor necrosis factorHomo sapiens (human)
positive regulation of smooth muscle cell proliferationTumor necrosis factorHomo sapiens (human)
positive regulation of inflammatory responseTumor necrosis factorHomo sapiens (human)
negative regulation of neurogenesisTumor necrosis factorHomo sapiens (human)
regulation of insulin secretionTumor necrosis factorHomo sapiens (human)
positive regulation of synaptic transmissionTumor necrosis factorHomo sapiens (human)
regulation of synapse organizationTumor necrosis factorHomo sapiens (human)
defense response to Gram-positive bacteriumTumor necrosis factorHomo sapiens (human)
cognitionTumor necrosis factorHomo sapiens (human)
leukocyte tethering or rollingTumor necrosis factorHomo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTumor necrosis factorHomo sapiens (human)
negative regulation of lipid catabolic processTumor necrosis factorHomo sapiens (human)
positive regulation of membrane protein ectodomain proteolysisTumor necrosis factorHomo sapiens (human)
positive regulation of DNA-binding transcription factor activityTumor necrosis factorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityTumor necrosis factorHomo sapiens (human)
positive regulation of protein transportTumor necrosis factorHomo sapiens (human)
response to glucocorticoidTumor necrosis factorHomo sapiens (human)
positive regulation of hair follicle developmentTumor necrosis factorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionTumor necrosis factorHomo sapiens (human)
regulation of synaptic transmission, glutamatergicTumor necrosis factorHomo sapiens (human)
positive regulation of glial cell proliferationTumor necrosis factorHomo sapiens (human)
positive regulation of vitamin D biosynthetic processTumor necrosis factorHomo sapiens (human)
positive regulation of calcidiol 1-monooxygenase activityTumor necrosis factorHomo sapiens (human)
epithelial cell proliferation involved in salivary gland morphogenesisTumor necrosis factorHomo sapiens (human)
regulation of branching involved in salivary gland morphogenesisTumor necrosis factorHomo sapiens (human)
negative regulation of vascular wound healingTumor necrosis factorHomo sapiens (human)
negative regulation of branching involved in lung morphogenesisTumor necrosis factorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeTumor necrosis factorHomo sapiens (human)
cellular response to lipopolysaccharideTumor necrosis factorHomo sapiens (human)
cellular response to amino acid stimulusTumor necrosis factorHomo sapiens (human)
cellular response to retinoic acidTumor necrosis factorHomo sapiens (human)
cellular response to nicotineTumor necrosis factorHomo sapiens (human)
cellular response to type II interferonTumor necrosis factorHomo sapiens (human)
cellular response to ionizing radiationTumor necrosis factorHomo sapiens (human)
positive regulation of mononuclear cell migrationTumor necrosis factorHomo sapiens (human)
positive regulation of podosome assemblyTumor necrosis factorHomo sapiens (human)
endothelial cell apoptotic processTumor necrosis factorHomo sapiens (human)
protein localization to plasma membraneTumor necrosis factorHomo sapiens (human)
negative regulation of oxidative phosphorylationTumor necrosis factorHomo sapiens (human)
inflammatory response to woundingTumor necrosis factorHomo sapiens (human)
extrinsic apoptotic signaling pathwayTumor necrosis factorHomo sapiens (human)
cellular response to toxic substanceTumor necrosis factorHomo sapiens (human)
liver regenerationTumor necrosis factorHomo sapiens (human)
necroptotic signaling pathwayTumor necrosis factorHomo sapiens (human)
negative regulation of bile acid secretionTumor necrosis factorHomo sapiens (human)
antiviral innate immune responseTumor necrosis factorHomo sapiens (human)
response to Gram-negative bacteriumTumor necrosis factorHomo sapiens (human)
positive regulation of neuroinflammatory responseTumor necrosis factorHomo sapiens (human)
negative regulation of amyloid-beta clearanceTumor necrosis factorHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionTumor necrosis factorHomo sapiens (human)
positive regulation of amyloid-beta formationTumor necrosis factorHomo sapiens (human)
response to L-glutamateTumor necrosis factorHomo sapiens (human)
positive regulation of neutrophil activationTumor necrosis factorHomo sapiens (human)
positive regulation of protein localization to plasma membraneTumor necrosis factorHomo sapiens (human)
regulation of establishment of endothelial barrierTumor necrosis factorHomo sapiens (human)
negative regulation of bicellular tight junction assemblyTumor necrosis factorHomo sapiens (human)
cellular response to amyloid-betaTumor necrosis factorHomo sapiens (human)
positive regulation of vascular associated smooth muscle cell proliferationTumor necrosis factorHomo sapiens (human)
positive regulation of leukocyte adhesion to vascular endothelial cellTumor necrosis factorHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellTumor necrosis factorHomo sapiens (human)
regulation of membrane lipid metabolic processTumor necrosis factorHomo sapiens (human)
response to 3,3',5-triiodo-L-thyronineTumor necrosis factorHomo sapiens (human)
response to gold nanoparticleTumor necrosis factorHomo sapiens (human)
positive regulation of protein localization to cell surfaceTumor necrosis factorHomo sapiens (human)
positive regulation of blood microparticle formationTumor necrosis factorHomo sapiens (human)
positive regulation of chemokine (C-X-C motif) ligand 2 productionTumor necrosis factorHomo sapiens (human)
positive regulation of hepatocyte proliferationTumor necrosis factorHomo sapiens (human)
regulation of endothelial cell apoptotic processTumor necrosis factorHomo sapiens (human)
regulation of reactive oxygen species metabolic processTumor necrosis factorHomo sapiens (human)
positive regulation of DNA biosynthetic processTumor necrosis factorHomo sapiens (human)
negative regulation of extrinsic apoptotic signaling pathway in absence of ligandTumor necrosis factorHomo sapiens (human)
positive regulation of extrinsic apoptotic signaling pathwayTumor necrosis factorHomo sapiens (human)
melanin biosynthetic process from tyrosineTyrosinaseHomo sapiens (human)
eye pigment biosynthetic processTyrosinaseHomo sapiens (human)
visual perceptionTyrosinaseHomo sapiens (human)
cell population proliferationTyrosinaseHomo sapiens (human)
response to UVTyrosinaseHomo sapiens (human)
response to blue lightTyrosinaseHomo sapiens (human)
response to vitamin DTyrosinaseHomo sapiens (human)
melanin biosynthetic processTyrosinaseHomo sapiens (human)
thymus developmentTyrosinaseHomo sapiens (human)
response to cAMPTyrosinaseHomo sapiens (human)
pigmentationTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingTumor necrosis factorHomo sapiens (human)
protease bindingTumor necrosis factorHomo sapiens (human)
cytokine activityTumor necrosis factorHomo sapiens (human)
tumor necrosis factor receptor bindingTumor necrosis factorHomo sapiens (human)
protein bindingTumor necrosis factorHomo sapiens (human)
death receptor agonist activityTumor necrosis factorHomo sapiens (human)
identical protein bindingTumor necrosis factorHomo sapiens (human)
tyrosinase activityTyrosinaseHomo sapiens (human)
copper ion bindingTyrosinaseHomo sapiens (human)
protein bindingTyrosinaseHomo sapiens (human)
identical protein bindingTyrosinaseHomo sapiens (human)
protein homodimerization activityTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
extracellular spaceTumor necrosis factorHomo sapiens (human)
phagocytic cupTumor necrosis factorHomo sapiens (human)
extracellular regionTumor necrosis factorHomo sapiens (human)
extracellular spaceTumor necrosis factorHomo sapiens (human)
plasma membraneTumor necrosis factorHomo sapiens (human)
external side of plasma membraneTumor necrosis factorHomo sapiens (human)
cell surfaceTumor necrosis factorHomo sapiens (human)
neuronal cell bodyTumor necrosis factorHomo sapiens (human)
membrane raftTumor necrosis factorHomo sapiens (human)
recycling endosomeTumor necrosis factorHomo sapiens (human)
cell surfaceTumor necrosis factorHomo sapiens (human)
cytoplasmTyrosinaseHomo sapiens (human)
lysosomeTyrosinaseHomo sapiens (human)
Golgi-associated vesicleTyrosinaseHomo sapiens (human)
melanosome membraneTyrosinaseHomo sapiens (human)
melanosomeTyrosinaseHomo sapiens (human)
intracellular membrane-bounded organelleTyrosinaseHomo sapiens (human)
perinuclear region of cytoplasmTyrosinaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (85)

Assay IDTitleYearJournalArticle
AID247402Growth inhibitory activity against human cancer cell line in the NCI's anticancer drug screening program2005Journal of medicinal chemistry, Mar-10, Volume: 48, Issue:5
CHMIS-C: a comprehensive herbal medicine information system for cancer.
AID1594855Antimicrobial activity against bacteria2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation of Sesquiterpene-Amino Acid Conjugates, Onopornoids A-D, and a Flavonoid Glucoside from Onopordum alexandrinum.
AID1617647Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
AID356014Antioxidant activity assessed as inhibition of AAPH-induced hemolysis in rat RBC after 3 hrs2003Journal of natural products, Jun, Volume: 66, Issue:6
Antioxidative glycosides from the leaves of Ligustrum robustum.
AID578760Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID528046Cytoprotective activity against doxorubicin-induced cytotoxicity in rat H9c2 cells assessed as cell viability after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
AID470161Stimulation of human MCF7 cell proliferation up to 100 uM after 96 hrs by alamar blue assay relative to estradiol2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1417091Inhibition of human DHODH at 100 uM2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID332707Activation of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID578843Cytotoxicity against human A2780 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID332931Therapeutic index, ratio of IC50 for human H9 cells to EC50 for HIV1 3B1994Journal of natural products, Jan, Volume: 57, Issue:1
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
AID1417094Inhibition of recombinant oligo-histidine-tagged Leishmania major DHODH expressed in Escherichia coli BL21(DE3) cells using DHO as substrate measured after 60 secs2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID470162Stimulation of human T47D cell proliferation up to 100 uM after 96 hrs by alamar blue assay relative to estradiol2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1503774Cytotoxicity against human HL cells assessed as cell viability at 50 uM after 72 hrs by resazurin dye based fluorescence assay relative to control2017Journal of natural products, 10-27, Volume: 80, Issue:10
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
AID1156795Retention time of the compound by chromatography2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1417130Antitrypanosomal activity against Trypanosoma brucei rhodesiense STIB 900 trypomastigotes after 72 hrs by Alamar Blue assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID332705Activation of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM1995Journal of natural products, Mar, Volume: 58, Issue:3
In vitro anticomplementary activity of constituents from Morinda morindoides.
AID456316ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID456318DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
AID455702Inhibition of Clostridium perfringens neuraminidase2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID1092162Antifungal activity against Athelia rolfsii assessed as mycelial growth inhibition at 100 ug/disk after 2 to 4 days by disk diffusion method relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID470164Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 10 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1417124Antitrypanosomal activity against Trypanosoma cruzi Tulahuen C2C4 trypomastigotes infected in rat skeletal myoblasts L-6 cells after 96 hrs by CPRG/Nonidet reagent based spectrophotometric method2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID1869396Antibacterial activity against Aneurinibacillus migulanus ATCC 9999 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID470166Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 50 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1156798Binding affinity to TNF-alpha (unknown origin)2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID528044Antioxidant activity assessed as ferrous ion chelating activity2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
AID1417122Antileishmanial activity against Leishmania donovani MHOM/ET/67/L82 amastigotes after 72 hrs by Alamar Blue assay2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID1092160Antifungal activity against Ceratocystis paradoxa assessed as mycelial growth inhibition at 100 ug/disc after 2 to 4 days by disk diffusion method relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID1460717Neuroprotective activity in human SH-SY5Y cells assessed as reduction in oxygen-glucose deprivation-induced cytotoxicity at 10 uM relative to untreated control2017Journal of natural products, 04-28, Volume: 80, Issue:4
Neuroprotective Caffeoylquinic Acid Derivatives from the Flowers of Chrysanthemum morifolium.
AID1092161Antifungal activity against Alternaria mali assessed as mycelial growth inhibition at 100 ug/disk after 2 to 4 days by disk diffusion method relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID404008Cytotoxicity against human KB cells
AID1869401Antifungal activity against Paecilomyces variotii ETH 114646 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID470169Antiestrogenic activity in human MCF7 cells assessed as inhibition of E2-enhanced cell proliferation at 0.1 to 100 uM after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1491046Inhibition of rat intestinal alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate pretreated for 10 mins followed by substrate addition measured after 30 mins2017Journal of natural products, 05-26, Volume: 80, Issue:5
α-Glucosidase Inhibitors from Salvia circinata.
AID1176142Cytotoxicity against mouse RAW264.7 cells at 50 uM by MTT assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID1236854Inhibition of Bacillus stearothermophilus alpha-glucosidase at 10 ug/ml2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.
AID1869402Antifungal activity against Phytophthora infestans CBS 430.90 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1092163Antifungal activity against Magnaporthe grisea assessed as mycelial growth inhibition at 100 ug/disk after 2 to 4 days by disk diffusion method relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID528043Antioxidant activity of the compound assessed as DPPH radical scavenging activity after 30 mins2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
AID1594853Inhibition of tyrosinase (unknown origin)2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation of Sesquiterpene-Amino Acid Conjugates, Onopornoids A-D, and a Flavonoid Glucoside from Onopordum alexandrinum.
AID1869400Antifungal activity against Penicillium chrysogenum IBWF assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID469266Antiinflammatory activity against mouse RAW264.7 cells assessed as inhibition of LPS-induced nitrite accumulation after 24 hrs by Griess reagent method2009Journal of natural products, Sep, Volume: 72, Issue:9
Triterpenoids and flavonoids from celery (Apium graveolens).
AID1266873Antioxidant activity assessed as reactive oxygen species scavenging activity2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavoalkaloids and Flavonoids from Astragalus monspessulanus.
AID578765Inhibition of P-gp expressed in A2780adr cells at 10 uM by calcein AM accumulation assay relative to verapamil2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID1869399Antifungal activity against Rhizomucor miehei assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1869397Antibacterial activity against Staphylococcus aureus ATCC 11632 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID1156796Binding affinity to Bcl-xL (unknown origin)2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID1775658Inhibition of LPS induced NO production in mouse RAW264.7 cells measured after 24 hrs by Griess reagent based assay2021Journal of natural products, 03-26, Volume: 84, Issue:3
Sesquiterpenoids from
AID455703Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase2009Bioorganic & medicinal chemistry, Oct-01, Volume: 17, Issue:19
Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities.
AID1236855Retention time of the compound by HPLC-SPE-NMR analysis2015Bioorganic & medicinal chemistry, Jul-01, Volume: 23, Issue:13
Acylated glucosylflavones as α-glucosidase inhibitors from Tinospora crispa leaf.
AID1594854Antimicrobial activity against Leishmania2019Journal of natural products, 06-28, Volume: 82, Issue:6
Isolation of Sesquiterpene-Amino Acid Conjugates, Onopornoids A-D, and a Flavonoid Glucoside from Onopordum alexandrinum.
AID470167Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 10 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1176144Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated nitric oxide production at 0.4 to 10 uM after 24 hrs by Griess assay2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID377143Antimicrobial activity against Bacillus subtilis IP 5832 after 24 hrs by agar well diffusion method1999Journal of natural products, Jun, Volume: 62, Issue:6
Flavones and sesquiterpene lactones from Achillea atrata subsp. multifida: antimicrobial activity.
AID515157Antimutagenic activity in Salmonella Typhimurium TA98 assessed as inhibition of 3-nitrofluoranthene-induced mutation by Ames test2010European journal of medicinal chemistry, Oct, Volume: 45, Issue:10
Multivariate QSAR study on the antimutagenic activity of flavonoids against 3-NFA on Salmonella typhimurium TA98.
AID377147Antimicrobial activity against Aspergillus niger after 48 hrs by agar well diffusion method1999Journal of natural products, Jun, Volume: 62, Issue:6
Flavones and sesquiterpene lactones from Achillea atrata subsp. multifida: antimicrobial activity.
AID470163Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 50 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID1869398Antibacterial activity against Pseudomonas aeruginosa ATCC 15442 assessed as reduction in bacterial growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID470165Antiestrogenic activity in human MCF7 cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 1 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID528045Antioxidant activity assessed as ABTS radical scavenging activity2010Bioorganic & medicinal chemistry letters, Nov-15, Volume: 20, Issue:22
Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells.
AID1156799Anticancer activity against human HepG2 cells assessed as cell viability after 24 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Prediction of anti-tumor chemical probes of a traditional Chinese medicine formula by HPLC fingerprinting combined with molecular docking.
AID332929Antiviral activity against HIV1 3B infected in human H9 cells assessed as inhibition of viral replication after 3 days by p24 antigen capture assay1994Journal of natural products, Jan, Volume: 57, Issue:1
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
AID578844Cytotoxicity against human MCF7 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID1176145Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-stimulated TNFalpha production at 0.4 to 10 uM by ELISA2015Bioorganic & medicinal chemistry letters, Jan-15, Volume: 25, Issue:2
Anti-inflammatory components of Chrysanthemum indicum flowers.
AID1092159Cytotoxicity against Spodoptera litura cells assessed as growth inhibition at 20 mg/L after 24 hr by MTT assay relative to control2012Bioorganic & medicinal chemistry letters, Sep-15, Volume: 22, Issue:18
A new antifungal and cytotoxic C-methylated flavone glycoside from Picea neoveitchii.
AID1417093Inhibition of recombinant oligo-histidine-tagged Leishmania major DHODH expressed in Escherichia coli BL21(DE3) cells at 100 uM using DHO as substrate measured after 60 secs2018European journal of medicinal chemistry, Sep-05, Volume: 157Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1869395Cytotoxicity against human HeLa S3 cells assessed as cell viability incubated for 48 hrs by microscopic analysis
AID1266872Hepatoprotective activity against tert-butyl hydroperoxide-induced oxidative stress in Wistar rat hepatocytes assessed as cell viability at 60 ug/ml by tryphan blue exclusion method (Rvb = 74%)2015Journal of natural products, Nov-25, Volume: 78, Issue:11
Flavoalkaloids and Flavonoids from Astragalus monspessulanus.
AID332930Cytotoxicity against human H9 cells after 3 days1994Journal of natural products, Jan, Volume: 57, Issue:1
Anti-AIDS agents, 10. Acacetin-7-O-beta-D-galactopyranoside, an anti-HIV principle from Chrysanthemum morifolium and a structure-activity correlation with some related flavonoids.
AID1869403Antifungal activity against Candida albicans ATCC 90028 assessed as reduction in fungal growth at 25 to 50 ug/ml incubated for 16 to 24 hrs by serial dilution assay
AID470168Antiestrogenic activity in human T47D cells assessed as drug level causing inhibition of 100 pM E2-enhanced cell proliferation to level equivalent to 1 pM E2 after 96 hrs by alamar blue assay2009Journal of natural products, Nov, Volume: 72, Issue:11
Antiestrogenic constituents of the Thai medicinal plants Capparis flavicans and Vitex glabrata.
AID404067In vivo antitumor activity against mouse S180 cells
AID578759Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining2011Bioorganic & medicinal chemistry, Mar-15, Volume: 19, Issue:6
Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).
AID338974Inhibition of cow milk xanthine oxidase at 50 ug/mL
AID1775659Cytotoxicity against mouse RAW264.7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay2021Journal of natural products, 03-26, Volume: 84, Issue:3
Sesquiterpenoids from
AID1460718Neuroprotective activity in human SH-SY5Y cells assessed as reduction in glutamate-induced cytotoxicity at 10 uM relative to untreated control2017Journal of natural products, 04-28, Volume: 80, Issue:4
Neuroprotective Caffeoylquinic Acid Derivatives from the Flowers of Chrysanthemum morifolium.
AID1698073Neuroprotective activity against glutamate-induced cell death in mouse HT-22 cells assessed as increase in cell viability after 24 hrs by EZ-Cytox assay
AID377146Antimicrobial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by agar well diffusion method1999Journal of natural products, Jun, Volume: 62, Issue:6
Flavones and sesquiterpene lactones from Achillea atrata subsp. multifida: antimicrobial activity.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (106)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.94)18.7374
1990's8 (7.55)18.2507
2000's28 (26.42)29.6817
2010's58 (54.72)24.3611
2020's11 (10.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.90%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other110 (99.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]